Journal Article Review Research Support, N.I.H., Extramural Ppublish 405 citations
PubMed: 33341248 DOI: 10.1016/j.tips.2020.11.009
Organ-on-a-Chip: A New Paradigm for Drug Development.
Trends Pharmacol Sci 42(2):119-133
Authors: Chao Ma, Yansong Peng, Hongtong Li, Weiqiang Chen
Affiliations
- Department of Mechanical and Aerospace Engineering, New York University, Brooklyn, NY 11201, USA; Department of Biomedical Engineering, New York University, Brooklyn, NY 11201, USA.
- Department of Biomedical Engineering, New York University, Brooklyn, NY 11201, USA.
- Department of Mechanical and Aerospace Engineering, New York University, Brooklyn, NY 11201, USA.
- Department of Mechanical and Aerospace Engineering, New York University, Brooklyn, NY 11201, USA; Department of Biomedical Engineering, New York University, Brooklyn, NY 11201, USA; Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
Abstract
The pharmaceutical industry has been desperately searching for efficient drug discovery methods. Organ-on-a-Chip, a cutting-edge technology that can emulate the physiological environment and functionality of human organs on a chip for disease modeling and drug testing, shows great potential for revolutionizing the drug development pipeline. However, successful translation of this novel engineering platform into routine pharmacological and medical scenarios remains to be realized. In this review, we discuss how the Organ-on-a-Chip technology can have critical roles in different preclinical stages of drug development and highlight the current challenges in translation and commercialization of this technology for the pharmacological and medical end-users. Moreover, this review sheds light on the future developmental trends and need for a next-generation Organ-on-a-Chip platform to bridge the gap between animal studies and clinical trials for the pharmaceutical industry.
MeSH
Drug Industry, Pharmaceutical Preparations, Technology, Microfluidics, Drug Development
Cited by
- Organ-on-a-Chip for Studying Gut-Brain Interaction Mediated by Extracellular Vesicles in the Gut Microenvironment. Int J Mol Sci, 2022
- Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects. Small, 2022
- Microphysiological Systems for Cancer Immunotherapy Research and Development. Adv Biol (Weinh), 2024
- Development of an in vitro microfluidic model to study the role of microenvironmental cells in oral cancer metastasis. F1000Res, 2024
- Biocompatible Heterogeneous Packaging and Laser-Assisted Fluid Interface Control for In Situ Sensor in Organ-on-a-Chip. Micromachines (Basel), 2025
- Future perspectives: advances in bone/cartilage organoid technology and clinical potential. Biomater Transl, 2025
- The 3C (Cell Culture, Computer Simulation, Clinical Trial) Solution for Optimizing the 3R (Replace, Reduction, Refine) Framework during Preclinical Research Involving Laboratory Animals. ACS Pharmacol Transl Sci, 2025
- Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer. J Transl Med, 2025
- In vitro high-content tissue models to address precision medicine challenges. Mol Aspects Med, 2023
- An Individual Patient's "Body" on Chips-How Organismoid Theory Can Translate Into Your Personal Precision Therapy Approach. Front Med (Lausanne), 2021
- Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics. Front Med (Lausanne), 2022
- Applications of Microfluidics and Organ-on-a-Chip in Cancer Research. Biosensors (Basel), 2022
- Three-Dimensional Cell Drawing Technique in Hydrogel Using Micro Injection System. Micromachines (Basel), 2022
- Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2022
- Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy. Cancer Commun (Lond), 2022
- Advanced models for respiratory disease and drug studies. Med Res Rev, 2023
- Design and Fabrication of Organ-on-Chips: Promises and Challenges. Micromachines (Basel), 2021
- Design, fabrication and characterization of a magnetite-chitosan coated iron-based metal-organic framework (Fe 3O 4@chitosan/MIL-100(Fe)) for efficient curcumin delivery as a magnetic nanocarrier. RSC Adv, 2025
- Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives. Biosensors (Basel), 2025
- A Review of the Applications, Benefits, and Challenges of Generative AI for Sustainable Toxicology. Curr Res Toxicol, 2025